Literature DB >> 19360418

Surgical considerations of spinal ependymomas in the pediatric population.

Wesley Hsu1, Gustavo Pradilla, Shlomi Constantini, George I Jallo.   

Abstract

OBJECTIVES: The objective of this manuscript is to discuss current management strategies regarding pediatric patients with intramedullary spinal cord ependymomas. Spinal ependymoma is the second most common spinal cord tumor in children. The clinical evaluation of these patients, operative techniques, postoperative management considerations, and long-term outcomes are discussed.
INTRODUCTION: The gold standard for the treatment of spinal ependymoma continues to be gross total resection. Patients with residual tumor postoperatively may benefit from adjuvant radiation therapy. Intraoperative monitoring is critical to minimize permanent postoperative neurologic deficit.
CONCLUSION: Patients requiring multilevel laminectomy may benefit from concomitant laminoplasty or instrumented fusion to avoid progressive spinal column deformity.

Entities:  

Mesh:

Year:  2009        PMID: 19360418     DOI: 10.1007/s00381-009-0882-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  43 in total

1.  Laminectomy versus laminoplasty for cervical myelopathy: brief report.

Authors:  S Hukuda; M Ogata; T Mochizuki; K Shichikawa
Journal:  J Bone Joint Surg Br       Date:  1988-03

2.  Radiotherapeutic management of adult intraspinal ependymomas.

Authors:  E G Shaw; R G Evans; B W Scheithauer; D M Ilstrup; J D Earle
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-03       Impact factor: 7.038

3.  Preliminary experience with ultrasonic aspiration in neurosurgery.

Authors:  E S Flamm; J Ransohoff; D Wuchinich; A Broadwin
Journal:  Neurosurgery       Date:  1978 May-Jun       Impact factor: 4.654

4.  Surgical management of holocord intramedullary spinal cord astrocytomas in children.

Authors:  F Epstein; N Epstein
Journal:  J Neurosurg       Date:  1981-06       Impact factor: 5.115

5.  Surgical treatment of spinal cord astrocytomas of childhood. A series of 19 patients.

Authors:  F Epstein; N Epstein
Journal:  J Neurosurg       Date:  1982-11       Impact factor: 5.115

6.  Intramedullary astrocytomas and ependymomas in the pediatric age group: a retrospective study.

Authors:  G Innocenzi; A Raco; G Cantore; A J Raimondi
Journal:  Childs Nerv Syst       Date:  1996-12       Impact factor: 1.475

7.  Ependymomas: results of radiation treatment.

Authors:  P G Garrett; W J Simpson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-08       Impact factor: 7.038

8.  Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study.

Authors:  A E Evans; J R Anderson; I B Lefkowitz-Boudreaux; J L Finlay
Journal:  Med Pediatr Oncol       Date:  1996-07

9.  A survey of 65 tumors within the spinal cord: surgical results and the importance of preoperative magnetic resonance imaging.

Authors:  J Brotchi; O Dewitte; M Levivier; D Balériaux; A Vandesteene; C Raftopoulos; J Flament-Durand; J Noterman
Journal:  Neurosurgery       Date:  1991-11       Impact factor: 4.654

10.  Long term outcome with post-operative radiation therapy for spinal canal ependymoma.

Authors:  Sasha H Wahab; Joseph R Simpson; Jeff M Michalski; David B Mansur
Journal:  J Neurooncol       Date:  2007-01-06       Impact factor: 4.506

View more
  2 in total

1.  Intraoperative changes in transcranial motor evoked potentials and somatosensory evoked potentials predicting outcome in children with intramedullary spinal cord tumors.

Authors:  Jason S Cheng; Michael E Ivan; Christopher J Stapleton; Alfredo Quinones-Hinojosa; Nalin Gupta; Kurtis I Auguste
Journal:  J Neurosurg Pediatr       Date:  2014-04-04       Impact factor: 2.375

2.  Intramedullary medullocervical ependymoma--surgical treatment, functional recovery, and long-term outcome.

Authors:  Da Li; Shu-Yu Hao; Zhen Wu; Gui-Jun Jia; Li-Wei Zhang; Jun-Ting Zhang
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-09-27       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.